Biologic-to-Biosimilar Switches Deemed Safe and Effective
Triple switching from infliximab biologic to biosimilar for IBD found no new safety or efficacy concerns.
Stay updated with breaking news from Endoscopy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Triple switching from infliximab biologic to biosimilar for IBD found no new safety or efficacy concerns.
Weight control medications may be needed to prevent weight regain.
Investigational treatment found to be highly effective in blocking gluten-specific T cells in celiac disease.
The giant health insurer has shelved the controversial prior authorization policy for GI endoscopy procedures. In its place is an 'advance notification program.'
Evangelical Community Hospital's ASC in Lewisburg, Pa. has been awarded a three-year quality and safety recognition by the American Society for Gastrointestinal